Expecting WASM audited filings any day, per previous conversations with CEO, Dr. James Garvin. Phone 210-767-2727. Looking for, not limited to, the following:
1. 40M in Asset Valuation 2. A/S 100M O/S 54.3M Float 761,750K 3. Lock-Up of 53M shares, for 2 years, issued for merger 4. Facilities in San Antonio, TX Cologne, Germany Birmingham, AL Tokyo, Japan, strategic alliance 5. Intellectual Property - Five Active Patents Four Pending Patents in US, EU, Japan 6. Increased revenues from - Its core ion drug screening market. Consumables Contract Research
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.